Stada Expands Oilatum Range To Meet Saudi Arabia’s Skin-Care Needs

Stada launches nine new Oilatum products in Saudi Arabia including “rich moisturising creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash.”

Stada's Oilatum range (Stada/Stada)

Eczema and dry skin sufferers in Saudia Arabia will be able to draw upon a wider range of Oilatum skin-care solutions thanks to significant investment by German brand owners Stada Arzneimittel.

“At Oilatum, we understand the cycle of dry skin and the challenges it presents for patients with eczema and chronic dryness, particularly in extreme conditions,” commented Ahmed El Barbary, general manager, Stada KSA+.

Atopic dermatitis (eczema) is a chronic condition affecting around 25% of children in Saudi Arabia and around 13% of adults, according to a Saudi Ministry of Health report.

“Recent research highlights an even broader prevalence when considering undiagnosed cases, emphasizing the urgent need for effective treatment options,” Stada added.

Saudi Arabia’s extreme climate, marked by high temperatures, low humidity, and heavy reliance on air conditioning further exacerbates these conditions, the firm continued, “making hydration and skin barrier protection essential components of eczema management.”

The nine new products – taking the range up to 11 in total – include “rich moisturizing creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash,” Stada explained.

The expanded range was unveiled at an exclusive event in Riyadh in January, which brought together dermatologists, doctors, and pharmacists from across Saudi Arabia and featured medical presentations by global and local experts on the impact of extreme weather conditions on skin health, as well as discussions on advancements in atopic dermatitis treatment.

“By equipping healthcare professionals in Saudi Arabia with these targeted solutions, we aim to help patients effectively manage atopic skin concerns, find relief from persistent irritation, and protect their skin from future discomfort,” El Barbary said.

Stada acquired Oilatum alongside five skin-care brands and a pediatric cough remedy from Haleon – then GlaxoSmithKline Consumer Healthcare – in 2019 for an undisclosed sum.

Stada CEO Peter Goldschmidt told HBW Insight at the time that the six brands had “great potential” for growth, particularly given the German company’s “rich heritage in skin care.”

“The skin-care category is a key focus [for us],” Goldschmidt declared, “and presents significant growth opportunities across territories.”

More from New Products

Haleon Launches ‘Prescription Strength’ Hayfever Remedy In The UK

 
• By 

Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”

Haleon’s US Eroxon Launch Falls Short Of Expectations

 
• By 

Consumer uptake of Eroxon - the first FDA-approved OTC ED treatment available in the US - has been slower than expected, according to Haleon, which says its working with retailers to build awareness.

Haleon Ready To Partner To Deliver Breakthrough CHC Innovation

 
• By 

Start-ups and individuals working on innovative consumer health concepts, in categories such as pain relief and dietary supplements, have the opportunity to access Haleon's resources and expertise to make their ideas a reality.

Haleon Launches 24 Hour Voltarol Medicated Plaster In The UK

 
• By 

Voltarol One A Day Muscle Pain Relief Medicated Plaster provides up to 24 hours relief from pain and inflammation, according to manufacturer Haleon.

More from Geography

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

Maxwellia Launches UK TV Campaign For Evana Showing Reality Of Menstruation

 
• By 

Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”

Over The Counter: Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

 
• By 

HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.